Table 3.
Characteristics | OverallN = 439 | No long COVIDN = 70 | Long COVIDN = 369 | Univariate analysisP-value |
---|---|---|---|---|
Events and interventions, N (%) | ||||
ICU admission | 77 (18.0) | 7 (10.0) | 70 (19.0) | 0.07 |
Ventilatory support | ||||
Nasal catheter | 219 (50.0) | 41 (59.0) | 178 (48.0) | 0.99 |
Face mask | 145 (33.0) | 22 (31.0) | 123 (33.0) | 0.92 |
Noninvasive ventilation | 37 (8.4) | 3 (4.3) | 34 (9.2) | 0.04 |
Mechanical ventilation | 37 (8.4) | 4 (5.7) | 33 (8.9) | 0.34 |
Hemodialysis | 9 (2.1) | 2 (2.9) | 7 (1.9) | 0.64 |
Shock/use of vasoactive amines | 12 (2.7) | 2 (2.9) | 10 (2.7) | 0.99 |
Pulmonary thromboembolism | 30 (6.8) | 7 (10.0) | 23 (6.2) | 0.30 |
Deep vein thrombosis | 2 (0.5) | 0 (0) | 2 (0.5) | 0.99 |
Presumed bacterial infection | 204 (46.0) | 35 (50.0) | 169 (46.0) | 0.52 |
Community infection | 177 (40.0) | 26 (37.0) | 151 (41.0) | 0.55 |
Nosocomial infection | 41 (9.3) | 5 (7.1) | 36 (9.8) | 0.49 |
Stroke | 1 (0.2) | 0 (0) | 1 (0.3) | 0.99 |
Acute myocardial infarction | 4 (0.9) | 1 (1.4) | 3 (0.8) | 0.50 |
Dexamethasone use | 435 (99.0) | 70 (100) | 365 (99.0) | 0.99 |
Azithromycin use | 205 (47.0) | 32 (46.0) | 173 (47) | 0.86 |
ICU, intensive care unit.